These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 23354657)
1. [Topical hemoglobin promotes wound healing of patients with venous leg ulcers]. Arenbergerova M; Engels P; Gkalpakiotis S; Dubská Z; Arenberger P Hautarzt; 2013 Mar; 64(3):180-6. PubMed ID: 23354657 [TBL] [Abstract][Full Text] [Related]
2. Chronic venous leg ulcers: is topical zinc the answer? A review of the literature. O'Connor S; Murphy S Adv Skin Wound Care; 2014 Jan; 27(1):35-44; quiz 45-6. PubMed ID: 24343392 [TBL] [Abstract][Full Text] [Related]
3. Antibiotics and antiseptics for venous leg ulcers. O'Meara S; Al-Kurdi D; Ologun Y; Ovington LG; Martyn-St James M; Richardson R Cochrane Database Syst Rev; 2013 Dec; (12):CD003557. PubMed ID: 24363048 [TBL] [Abstract][Full Text] [Related]
4. Randomized, controlled study of innovative spray formulation containing ozonated oil and α-bisabolol in the topical treatment of chronic venous leg ulcers. Solovăstru LG; Stîncanu A; De Ascentii A; Capparé G; Mattana P; Vâţă D Adv Skin Wound Care; 2015 Sep; 28(9):406-9. PubMed ID: 26280699 [TBL] [Abstract][Full Text] [Related]
5. Antibiotics and antiseptics for venous leg ulcers. O'Meara S; Al-Kurdi D; Ovington LG Cochrane Database Syst Rev; 2008 Jan; (1):CD003557. PubMed ID: 18254024 [TBL] [Abstract][Full Text] [Related]
6. Antibiotics and antiseptics for venous leg ulcers. O'Meara S; Al-Kurdi D; Ologun Y; Ovington LG Cochrane Database Syst Rev; 2010 Jan; (1):CD003557. PubMed ID: 20091548 [TBL] [Abstract][Full Text] [Related]
7. The use of topical phenytoin for healing of chronic venous ulcerations. Hokkam E; El-Labban G; Shams M; Rifaat S; El-Mezaien M Int J Surg; 2011; 9(4):335-8. PubMed ID: 21338720 [TBL] [Abstract][Full Text] [Related]
8. Expected outcomes from topical haemoglobin spray in non-healing and worsening venous leg ulcers. Arenberger P; Elg F; Petyt J; Cutting K J Wound Care; 2015 May; 24(5):228, 230-2, 236. PubMed ID: 25970759 [TBL] [Abstract][Full Text] [Related]
9. Simvastatin as a novel therapeutic agent for venous ulcers: a randomized, double-blind, placebo-controlled trial. Evangelista MT; Casintahan MF; Villafuerte LL Br J Dermatol; 2014 May; 170(5):1151-7. PubMed ID: 24506834 [TBL] [Abstract][Full Text] [Related]
10. Aspirin in venous leg ulcer study (ASPiVLU): study protocol for a randomised controlled trial. Weller CD; Barker A; Darby I; Haines T; Underwood M; Ward S; Aldons P; Dapiran E; Madan JJ; Loveland P; Sinha S; Vicaretti M; Wolfe R; Woodward M; McNeil J Trials; 2016 Apr; 17():192. PubMed ID: 27068695 [TBL] [Abstract][Full Text] [Related]
11. The effect of amelogenins (Xelma) on hard-to-heal venous leg ulcers. Vowden P; Romanelli M; Peter R; Boström A; Josefsson A; Stege H Wound Repair Regen; 2006; 14(3):240-6. PubMed ID: 16808801 [TBL] [Abstract][Full Text] [Related]
12. Results of the clinical examination of an ointment with marigold (Calendula officinalis) extract in the treatment of venous leg ulcers. Duran V; Matic M; Jovanovć M; Mimica N; Gajinov Z; Poljacki M; Boza P Int J Tissue React; 2005; 27(3):101-6. PubMed ID: 16372475 [TBL] [Abstract][Full Text] [Related]
13. Oxygenation Status in Chronic Leg Ulcer After Topical Hemoglobin Application May Act as a Surrogate Marker to Find the Best Treatment Strategy and to Avoid Ineffective Conservative Long-term Therapy. Petri M; Stoffels I; Griewank K; Jose J; Engels P; Schulz A; Pötzschke H; Jansen P; Schadendorf D; Dissemond J; Klode J Mol Imaging Biol; 2018 Feb; 20(1):124-130. PubMed ID: 28702902 [TBL] [Abstract][Full Text] [Related]
14. Some effects of a topical collagen-based matrix on the microcirculation and wound healing in patients with chronic venous leg ulcers: preliminary observations. Wollina U; Schmidt WD; Krönert C; Nelskamp C; Scheibe A; Fassler D Int J Low Extrem Wounds; 2005 Dec; 4(4):214-24. PubMed ID: 16286373 [TBL] [Abstract][Full Text] [Related]
16. Possible role of coagulation factor XIII in the pathogenesis of venous leg ulcers. Peschen M; Thimm C; Weyl A; Weiss JM; Kurz H; Augustin M; Simon JC; Schöpf E; Vanscheidt W Vasa; 1998 May; 27(2):89-93. PubMed ID: 9612112 [TBL] [Abstract][Full Text] [Related]
17. Novel Multivalent Wound-Healing Ointment Provides Bioburden Control and Moisture Management: A Retrospective Registry Data Analysis. Serena T; Connell H; McConnell S; Patel K; Doner B; Sabo M; Miller M; Serena L; Le LT; Goldsmith D; Chung J Adv Skin Wound Care; 2016 Oct; 29(10):461-8. PubMed ID: 27632443 [TBL] [Abstract][Full Text] [Related]
18. Silver sulfadiazine for the treatment of partial-thickness burns and venous stasis ulcers. Miller AC; Rashid RM; Falzon L; Elamin EM; Zehtabchi S J Am Acad Dermatol; 2012 May; 66(5):e159-65. PubMed ID: 20724028 [TBL] [Abstract][Full Text] [Related]
19. Impact of omega-3 fatty acid oral therapy on healing of chronic venous leg ulcers in older adults: Study protocol for a randomized controlled single-center trial. McDaniel JC; Rausch J; Tan A Trials; 2020 Jan; 21(1):93. PubMed ID: 31948466 [TBL] [Abstract][Full Text] [Related]
20. Early versus deferred endovenous ablation of superficial venous reflux in patients with venous ulceration: the EVRA RCT. Gohel MS; Heatley F; Liu X; Bradbury A; Bulbulia R; Cullum N; Epstein DM; Nyamekye I; Poskitt KR; Renton S; Warwick J; Davies AH Health Technol Assess; 2019 May; 23(24):1-96. PubMed ID: 31140402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]